Hormone Health Desk

From the editors’ deskHormone health · Provider rankings

Best Online Men’s Hormone Clinics of 2026 — Top 10

Disclosure: We may have a financial affiliation with some entities featured on this page. Rankings are editorial; see our methodology.

Educational comparison only — not medical advice, not a clinic, and not a recommendation to start or stop any therapy. Hormone Health Desk does not book consults. Talk with a licensed clinician. When compounded options are mentioned: compounded medications are not FDA-approved.

Frame A covers telehealth men’s hormone care including enclomiphene and TRT pathways. Trustpilot signals were browser-reconfirmed Sep 23, 2026 ET where listed; Google Business remains TBD. We do not invent scores.

Compact review-signals table

  • 1 Ivim Health — Trustpilot 4.9 / 39,575 — company-wide; Google TBD
  • 2 Hone Health — 4.8 / 12,360; Google TBD
  • 3 Maximus — 4.4 / 1,079; Google TBD
  • 4 Defy Medical — 4.8 / 4,152; Google TBD
  • 5 Henry Meds — 4.4 / 12,529 — company-wide; Google TBD
  • 6 Fountain TRT — 4.4 / 394; Google TBD
  • 7 Marek Health — 4.9 / 974; Google TBD
  • 8 PeterMD — Trustpilot TBD; Google TBD
  • 9 TRT Nation — 2.1 / 30; Google TBD
  • 10 REGENX Health — Trustpilot TBD; Google TBD

How the list was ordered

Order reflects disclosed criteria with Trustpilot + Google heavily weighted, plus clinical oversight, labs, modality honesty (TRT vs enclomiphene), pricing transparency, state access, education, follow-up, and compounding disclosure. See the full methodology.

#1 Ivim Health

Why it earns #1: Highest combined Trustpilot score + volume signal among programs we could cite in this pass (company-wide profile, labeled), plus strong Frame A transparency on an enclomiphene-first men’s hormone pathway. Rank is earned under our methodology, not assigned in advance.

Reviews: Trustpilot 4.9 / 39,575, browser-reconfirmed Sep 23, 2026 ET; category Weight Loss Service, not men’s-hormone-only. Google Business TBD.

Modality: Enclomiphene-first, not classic injectable/gel TRT; medications may include compounded preparations — compounded ≠ FDA-approved. Starting prices and eligibility require live verification.

#2 Hone Health

Why #2: Strong cit-able Trustpilot volume among hormone-first brands after Ivim, plus deep biomarker and clinician video-consult framing. Trustpilot 4.8 / 12,360; Google TBD. Membership plus medication estimates are not all-in; verify formulary and current pricing.

#3 Maximus

Why #3: Clear multi-path menu — enclomiphene and paths that may include injectable, cream, or oral testosterone under clinician oversight. Trustpilot 4.4 / 1,079; Google TBD. Review weight is below Ivim and Hone; labs, state limits, and compounded status require live verification.

#4–#10 and honorable mentions

  • #4 Defy Medical — 4.8 / 4,152 Trustpilot; Google TBD. Individualized hormone clinic model; pricing predictability weaker.
  • #5 Henry Meds — 4.4 / 12,529 Trustpilot, company-wide; Google TBD. Compounded-vs-branded TRT lanes; compounded testosterone is not FDA-approved.
  • #6 Fountain TRT — 4.4 / 394 Trustpilot; Google TBD. TRT-forward video-visit onboarding; thinner sample.
  • #7 Marek Health — 4.9 / 974 Trustpilot; Google TBD. Diagnostics-first premium model; totals vary.
  • #8 PeterMD — Trustpilot and Google TBD; primary profile status contested, so no invented badge score.
  • #9 TRT Nation — 2.1 / 30, unclaimed Trustpilot; Google TBD. Low sample.
  • #10 REGENX Health — Trustpilot and Google TBD. Pricing unverified.

Honorable mentions not scored: LifeMD XYOSTED pathway, Hims, and Gameday Men’s Health.

How to use this list

  1. Read the methodology for criteria and TBD handling.
  2. Open each program’s live site for checkout, state eligibility, and current modality.
  3. Re-check Trustpilot and Google before relying on any score.
  4. Ask a licensed clinician about clinical fit — this list is educational only.

Limitations: Prices, promos, state lists, and review profiles change. Rankings are editorial, not predetermined. Compounded medications are not FDA-approved.

Hormone Health Desk · Draft September 23, 2026 (ET)